These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 9651158)

  • 41. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors.
    Liu R; Hu RJ; Zhang P; Skolnick P; Cook JM
    J Med Chem; 1996 Apr; 39(9):1928-34. PubMed ID: 8627617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
    Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
    J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
    J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.
    Wong G; Lyon T; Skolnick P
    Mol Pharmacol; 1994 Dec; 46(6):1056-62. PubMed ID: 7808424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of benzo-fused benzodiazepines employed as probes of the agonist pharmacophore of benzodiazepine receptors.
    Zhang W; Koehler KF; Harris B; Skolnick P; Cook JM
    J Med Chem; 1994 Mar; 37(6):745-57. PubMed ID: 8145224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
    Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
    J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
    Schmid L; Bottlaender M; Brouillet E; Fuseau C; Mazière M
    J Pharmacol Exp Ther; 1996 Mar; 276(3):977-83. PubMed ID: 8786578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
    Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
    J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels.
    Collins I; Moyes C; Davey WB; Rowley M; Bromidge FA; Quirk K; Atack JR; McKernan RM; Thompson SA; Wafford K; Dawson GR; Pike A; Sohal B; Tsou NN; Ball RG; Castro JL
    J Med Chem; 2002 Apr; 45(9):1887-900. PubMed ID: 11960500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of GABAA/benzodiazepine receptors containing alpha 1 and alpha 5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys.
    Lelas S; Rowlett JK; Spealman RD; Cook JM; Ma C; Li X; Yin W
    Psychopharmacology (Berl); 2002 May; 161(2):180-8. PubMed ID: 11981598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
    J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural features controlling the binding of beta-carbolines to the benzodiazepine receptor.
    Ferretti V; Gilli P; Borea PA
    Acta Crystallogr B; 2004 Aug; 60(Pt 4):481-9. PubMed ID: 15258407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral effects of the beta-carboline derivatives ZK 93423 and ZK 91296 in squirrel monkeys: comparison with lorazepam and suriclone.
    Wettstein JG; Spealman RD
    J Pharmacol Exp Ther; 1987 Feb; 240(2):471-5. PubMed ID: 2879907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors.
    Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Gesi M; Martini C; Giannaccini G; Lucacchini A
    J Med Chem; 1998 Sep; 41(20):3821-30. PubMed ID: 9748357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacophore/receptor models for GABA(A)/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes.
    He X; Huang Q; Ma C; Yu S; McKernan R; Cook JM
    Drug Des Discov; 2000; 17(2):131-71. PubMed ID: 11045902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
    Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
    Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach.
    Allen MS; LaLoggia AJ; Dorn LJ; Martin MJ; Costantino G; Hagen TJ; Koehler KF; Skolnick P; Cook JM
    J Med Chem; 1992 Oct; 35(22):4001-10. PubMed ID: 1331452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.